Both in Pharmaceuticals
Crescent Biopharma vs Tilray Brands
Over the past year CBIO returned +20.1% and TLRY returned −78.6%; their daily moves had a correlation of 0.14.
CBIO +20.1% TLRY −78.6%Growth of $1, one year, split-adjusted
| Metric | CBIO | TLRY |
|---|---|---|
| Price | $14.76 | $3.95 |
| Market cap | $548.3M | $583.7M |
| Today | +1.58% | −1.74% |
| 1 month | −16.8% | −13.9% |
| 6 months | −11.2% | −34.1% |
| Year to date | +24.5% | −56.3% |
| 1 year | +18.7% | −65.7% |
| Revenue growth (YoY) | — | +25.5% |
| Gross margin | — | 32.1% |
| Net margin | — | −17.6% |
| P/E (TTM) | — | — |
| Price / sales | 46.1× | 0.6× |
| Net cash | $171.6M | $83.9M |
| Dividend yield | — | — |
| Volatility (60d) | 77.0% | 46.2% |
| Short % of float | 16.3% | 14.4% |
| Next earnings | — | Oct 8, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).